RecruitingNot ApplicableNCT07114510

Optimal Ventilation for Cardiac Arrest

OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)


Sponsor

Children's Hospital of Philadelphia

Enrollment

1,530 participants

Start Date

Oct 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Pediatric cardiac arrest is a life-threatening problem affecting \>15,000 hospitalized children each year. Less than half of these children survive to hospital discharge, and neurologic morbidity is common among survivors. The objective of this study is to evaluate the effectiveness of the OPTI-VENT bundle to improve survival to discharge with favorable neurological outcome (Pediatric Cerebral Performance Category Score 1-2 or no change from baseline) among children receiving at least 1 minute of CPR.


Eligibility

Min Age: 37 WeeksMax Age: 18 Years

Inclusion Criteria2

  • Invasive airway in place at the start of CPR or airway placed within the first 5 minutes
  • Received at least 1 minute of CPR.

Exclusion Criteria4

  • Lack of commitment to aggressive ICU therapies (e.g., CPR performed as part of end-of-life care.
  • Brain death determination prior to the CPR event.
  • Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes).
  • Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROPTI-VENT Bundle

Provider Education: During a brief (\<2 minute) bedside education, the educator will 1) review the CPR ventilation rate targets for age, and 2) ensure the provider has a cue card of current rate recommendations on his/her person. Compliance will be defined as performance of at least 30 trainings per unit per month. We will record provider discipline and time since last training as a surrogate of training spread. Educators will leverage these two-minute trainings to review the patient's current ventilator settings as an initial target during CPR to ensure adequate chest rise. Additionally, a focus on CPR ventilation rates will be integrated into resuscitation education or quality meetings for all disciplines. "Report cards" detailing unit-level performance will be generated by the study team for review during site monthly presentations. Point-of-Care Guidance: A metronome will be deployed to all cardiac arrests using a smart phone application.

OTHERTransition

There will be a 2-month transition period for study sites beginning study enrollment using standard ICU practices as they onboard to the study intervention.

OTHERNone - control

Control - no intervention


Locations(20)

CHOC

Orange, California, United States

Lucile Packard Children's Hospital Stanford

Palo Alto, California, United States

Children's Hospital Colorado

Denver, Colorado, United States

Nemours Children's Health

Wilmington, Delaware, United States

Children's Healthcare of Atlanta

Atlanta, Georgia, United States

Riley Children's Health

Indianapolis, Indiana, United States

Stead Family Children's Hospital

Iowa City, Iowa, United States

Boston Children's Hospital

Boston, Massachusetts, United States

Washington University in St. Louis

St Louis, Missouri, United States

Cohen Children's Medical Center

New Hyde Park, New York, United States

UNC Children's Hospital

Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Nationwide Children's Hospital

Columbus, Ohio, United States

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

Dell Children's Medical Center

Austin, Texas, United States

Medical City Children's Hospital

Dallas, Texas, United States

UT Southwestern Medical Center

Dallas, Texas, United States

Children's Hospital of Richmond at VCU

Richmond, Virginia, United States

Seattle Children's

Seattle, Washington, United States

Children's Wisconsin

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07114510


Related Trials